Inulin
VARIOUS
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Inulin is a drug catalogued in DrugCentral. It was first approved by the FDA in 1940. Recorded indications include Renal function study.
- Indications: Renal function study.
- ATC code: V04CH01 (Tests for renal function and ureteral injuries).
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Renal function study
Contraindications (11)
- Arteriosclerosis obliterans
- Constipation
- Dehydration
- Hypercalcemia
- Hyperparathyroidism
- Hyperphosphatemia
- Hypervitaminosis D
- Kidney disease
- Kidney stone
- Osteolysis
- Sarcoidosis
Regulatory approvals (2)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 2021-08-25 | PMDA | — | FUJI YAKUHIN Co., Ltd | |
| 1940-04-30 | FDA | — | ISO TEX |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
V04CH01 | VARIOUS › DIAGNOSTIC AGENTS › OTHER DIAGNOSTIC AGENTS › Tests for renal function and ureteral injuries |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Pneumonia aspiration | 169.8 |
| Coma | 148.7 |
| Gastrooesophageal reflux disease | 136.2 |
| Somnolence | 112.0 |
Chemical structure
| Molecular formula | — |
|---|---|
| Molecular weight | — |
| CAS number | — |
| InChIKey | — |
| PubChem CID | — |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Inulin used for?
DrugCentral lists the following indications for Inulin: Renal function study.
When was Inulin first approved?
Inulin was first approved by the FDA in 1940.
Browse: all drugs starting with I · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1447 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1201646 — compound record and bioactivity
- DrugBank DB00638 — drug record
- FDA UNII JOS53KRJ01 — substance identity
- DailyMed: FDA labels for Inulin — current prescribing information (label search)
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.